Replimune Group, Inc.

REPL ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Nov 9, 2026
SCHEDULE 13G/A Nov 9, 2026
10-Q/A Nov 6, 2026 FORM 10-Q/A
4 Nov 3, 2026 OWNERSHIP DOCUMENT
144 Nov 3, 2026
144 Nov 2, 2026
144 Oct 30, 2026
144 Oct 28, 2026
10-Q Oct 28, 2026 10-Q
8-K Oct 28, 2026 FORM 8-K
8-K Sep 16, 2026 FORM 8-K
4 Aug 24, 2026 OWNERSHIP DOCUMENT
4 Aug 19, 2026 OWNERSHIP DOCUMENT
S-3ASR Aug 14, 2026 S-3ASR
10-Q Aug 14, 2026 10-Q
SCHEDULE 13G/A Aug 14, 2026
8-K Aug 14, 2026 FORM 8-K
4 Aug 12, 2026 OWNERSHIP DOCUMENT
4 Aug 12, 2026 OWNERSHIP DOCUMENT
4 Aug 12, 2026 OWNERSHIP DOCUMENT
4 Aug 12, 2026 OWNERSHIP DOCUMENT
SCHEDULE 13D/A Aug 11, 2026
4 Aug 11, 2026 4
8-K/A Aug 11, 2026 FORM 8-K/A
SCHEDULE 13G Aug 10, 2026
← Newer Page 1 of 27 · 660 filings Older →